Previous studies have shown that human serum, guinea pig and human red cells, and human white cells contain low and high M, substances that induce gonococcal strains to become serum resistant (1-4) and change lipooligosaccharide (LOS)' pattern (5, 6) . In more recent studies, the same investigators have shown that the low Mr substance in-blood is cytidine monophospho-N-acetylneuraminic acid (CMP-NANA) or a related compound (7,8) . These studies suggest that in vivo, sufficient concentrations of CMP-NANA might induce serum resistance by sialylation of LOS. Because gonococci are not able to synthesize CMP-NANA and it is not present in the usual media, previous in vitro studies of gonococcal LOS may have dealt with different LOS structures than those that occur in vivo .Each gonococcal strain makes multiple types of LOS (9)(10)(11), and the physical (Mr) and antigenic heterogeneity of a strain's LOS reflects physicochemical differences in their glycan moieties (10, 12). mAbs 3F11 and 06B4 identify epitopes on meningococcal and gonococcal LOS that are immunochemically similar to Galo1-4G1cNAc-containing molecules present in human erythrocytes and on other human cells (13) . These epitopes are conserved on gonococcal LOS (11,14) and are variably expressed This work was supported by U. S .